UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 160 filers reported holding UNIQURE NV in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,442,650 | -41.4% | 215,000 | 0.0% | 0.47% | -41.7% |
| Q2 2023 | $2,463,900 | -67.4% | 215,000 | -42.7% | 0.81% | -63.6% |
| Q1 2023 | $7,553,000 | +176.2% | 375,000 | +971.4% | 2.23% | +293.7% |
| Q2 2019 | $2,735,000 | -10.9% | 35,000 | -76.7% | 0.57% | -58.9% |
| Q3 2015 | $3,068,000 | -38.6% | 150,000 | -18.9% | 1.38% | -14.7% |
| Q2 2015 | $4,995,000 | – | 185,000 | – | 1.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |